5. Stockholders' Equity (Tables)

9 Months Ended

Mar. 31, 2017

Schedule of share-based compensation expense

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2017		2016		2017		2016
	(In thousands)
Cost of revenue	$	12	$	14	$	36	$	52
Selling, general and administrative		169		131		480		484
Research and development		43		41		129		135
Total share-based compensation expense	$	224	$	186	$	645	$	671

Schedule of unrecognized share-based compensation expense

	Remaining		Remaining
	Unrecognized		Weighted-
	Compensation		Average Years
	Expense		To Recognize
	(In thousands)
Stock options	$	1,395		3.0
RSUs		408		2.8
Stock purchase rights under ESPP		128		1.1

Stock Options [Member]

Summary of stock option activity

				Weighted-
				Average
	Number of			Exercise Price
	Shares			per Share
	(In thousands)
Balance of options outstanding at June 30, 2016		3,606		$	1.85
Granted		864			1.61
Forfeited		(45	)		1.42
Expired		(74	)		4.22
Exercised		(99	)		1.85
Balance of options outstanding at March 31, 2017		4,252		$	1.77

Restricted Stock Units (RSUs) [Member]

Summary of other-than-option activity

				Weighted-
				Average
				Grant Date
	Number of			Fair Value
	Shares			per Share
	(In thousands)
Balance of RSUs outstanding at June 30, 2016		460		$	1.10
Granted		85			1.81
Vested		(198	)		1.10
Cancelled / forfeited		–			–
Balance of RSUs outstanding at March 31, 2017		347		$	1.27

ESPP [Member]

Summary of other-than-option activity

	Number of
	Shares
	(In thousands)
Shares available for issuance at June 30, 2016		736
Shares issued		(113	)
Shares available for issuance at March 31, 2017		623